Helicobacter pylori Dormant States Are Affected by Vitamin C

Helicobacter pylori colonizes human gastric mucosa, overcoming stressful conditions and entering in a dormant state. This study evaluated: (i) H. pylori’s physiological changes from active to viable-but-non-culturable (VBNC) and persister (AP) states, establishing times/conditions; (ii) the ability of vitamin C to interfere with dormancy generation/resuscitation. A dormant state was induced in clinical MDR H. pylori 10A/13 by: nutrient starvation (for VBNC generation), incubating in an unenriched medium (Brucella broth) or saline solution (SS), and (for AP generation) treatment with 10xMIC amoxicillin (AMX). The samples were monitored after 24, 48, and 72 h, 8–14 days by OD600, CFUs/mL, Live/Dead staining, and an MTT viability test. Afterwards, vitamin C was added to the H. pylori suspension before/after the generation of dormant states, and monitoring took place at 24, 48, and 72 h. The VBNC state was generated after 8 days in SS, and the AP state in AMX for 48 h. Vitamin C reduced its entry into a VBNC state. In AP cells, Vitamin C delayed entry, decreasing viable coccal cells and increasing bacillary/U-shaped bacteria. Vitamin C increased resuscitation (60%) in the VBNC state and reduced the aggregates of the AP state. Vitamin C reduced the incidence of dormant states, promoting the resuscitation rate. Pretreatment with Vitamin C could favor the selection of microbial vegetative forms that are more susceptible to H. pylori therapeutical schemes.

[1]  M. Zali,et al.  The Effects of Vitamins and Micronutrients on Helicobacter pylori Pathogenicity, Survival, and Eradication: A Crosstalk between Micronutrients and Immune System , 2022, Journal of immunology research.

[2]  N. Dong,et al.  Bactericidal, anti-biofilm, and anti-virulence activity of vitamin C against carbapenem-resistant hypervirulent Klebsiella pneumoniae , 2022, iScience.

[3]  Y. Yamaoka,et al.  Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications , 2021, Nature Reviews Gastroenterology & Hepatology.

[4]  P. Krzyżek Toxin-Antitoxin Systems - A New Player in Morphological Transformation of Antibiotic-Exposed Helicobacter pylori? , 2021, Frontiers in Cellular and Infection Microbiology.

[5]  J. Jia,et al.  SpoT-Mediated NapA Upregulation Promotes Oxidative Stress-Induced Helicobacter pylori Biofilm Formation and Confers Multidrug Resistance , 2021, Antimicrobial Agents and Chemotherapy.

[6]  Vasiliy Ivanovich Reshetnyak,et al.  Helicobacter pylori: Commensal, symbiont or pathogen? , 2021, World journal of gastroenterology.

[7]  L. Cellini,et al.  Searching for New Tools to Counteract the Helicobacter pylori Resistance: The Positive Action of Resveratrol Derivatives , 2020, Antibiotics.

[8]  D. Sachdev,et al.  In vitro and in situ abrogation of biofilm formation in E. coli by vitamin C through ROS generation, disruption of quorum sensing and exopolysaccharide production. , 2020, Food chemistry.

[9]  E. Abamor,et al.  Resuscitation of the Helicobacter pylori Coccoid Forms by Resuscitation Promoter Factor Obtained from Micrococcus Luteus , 2020, Current Microbiology.

[10]  G. Péhau-Arnaudet,et al.  A peptide of a type I toxin−antitoxin system induces Helicobacter pylori morphological transformation from spiral shape to coccoids , 2019, Proceedings of the National Academy of Sciences.

[11]  L. Cellini,et al.  Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains , 2019, Scientific Reports.

[12]  Hongbin Tu,et al.  Vitamin C and Helicobacter pylori Infection: Current Knowledge and Future Prospects , 2018, Front. Physiol..

[13]  J. Oliver,et al.  Relationship between the Viable but Nonculturable State and Antibiotic Persister Cells , 2018, Journal of bacteriology.

[14]  S. Tabrez,et al.  Vitamin C: A Preventative, Therapeutic Agent Against Helicobacter pylori , 2018, Cureus.

[15]  G. Perez-Perez,et al.  Helicobacter pylori the Latent Human Pathogen or an Ancestral Commensal Organism , 2018, Front. Microbiol..

[16]  C. Vilchèze,et al.  Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice , 2018, Antimicrobial Agents and Chemotherapy.

[17]  V. Reshetnyak,et al.  Significance of dormant forms of Helicobacter pylori in ulcerogenesis , 2017, World journal of gastroenterology.

[18]  Chii-Wann Lin,et al.  Current Perspectives on Viable but Non-culturable State in Foodborne Pathogens , 2017, Front. Microbiol..

[19]  M. Levine,et al.  Vitamin C: the known and the unknown and Goldilocks. , 2016, Oral diseases.

[20]  Ryan M. Baxter,et al.  Viable but Nonculturable and Persister Cells Coexist Stochastically and Are Induced by Human Serum , 2015, Infection and Immunity.

[21]  Laam Li,et al.  The importance of the viable but non-culturable state in human bacterial pathogens , 2014, Front. Microbiol..

[22]  J. Faghri,et al.  Morphological and Bactericidal Effects of Different Antibiotics on Helicobacter pylori , 2014, Jundishapur journal of microbiology.

[23]  G. Grosso,et al.  Effects of vitamin C on health: a review of evidence. , 2013, Frontiers in bioscience.

[24]  M. L. Hartung,et al.  Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori , 2013, Nature Reviews Microbiology.

[25]  J. Faghri,et al.  Assessment of cagE and babA mRNA Expression During Morphological Conversion of Helicobacter pylori From Spiral to Coccoid , 2013, Current Microbiology.

[26]  A. Luca,et al.  The Helicobacter Pylori Protein HspB Interferes With Nrf2/Keap1 Pathway Altering The Antioxidant Response of Ags Cells , 2012, Helicobacter.

[27]  Gopal Jee Gopal,et al.  Vitamin-C as anti-Helicobacter pylori agent: More prophylactic than curative- Critical review , 2011, Indian journal of pharmacology.

[28]  B. Krajewska,et al.  Urease activity and l-ascorbic acid , 2011, Journal of enzyme inhibition and medicinal chemistry.

[29]  Keith T. Wilson,et al.  Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk , 2010, Clinical Microbiology Reviews.

[30]  J. Oliver,et al.  Recent findings on the viable but nonculturable state in pathogenic bacteria. , 2010, FEMS microbiology reviews.

[31]  M. Molaei,et al.  The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[32]  M. Blaser,et al.  Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. , 2009, The Journal of clinical investigation.

[33]  B. Yaşar,et al.  Oxidative Stress in Helicobacter pylori Infection: Does Supplementation with Vitamins C and E Increase the Eradication Rate? , 2009, Helicobacter.

[34]  L. Cellini,et al.  Dynamic colonization of Helicobacter pylori in human gastric mucosa , 2008, Scandinavian journal of gastroenterology.

[35]  K. Guillemin,et al.  The Stringent Response Is Required for Helicobacter pylori Survival of Stationary Phase, Exposure to Acid, and Aerobic Shock , 2006, Journal of bacteriology.

[36]  K. Naidu Vitamin C in human health and disease is still a mystery ? An overview , 2003, Nutrition journal.

[37]  S. Passi,et al.  Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia , 2003, Gut.

[38]  Y. Naito,et al.  Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. , 2002, Free radical biology & medicine.

[39]  G. Bogosian,et al.  A matter of bacterial life and death , 2001, EMBO reports.

[40]  M. de Pedro,et al.  The Morphological Transition of Helicobacter pyloriCells from Spiral to Coccoid Is Preceded by a Substantial Modification of the Cell Wall , 1999, Journal of bacteriology.

[41]  P. Ernst,et al.  Review article: the role of inflammation in the pathogenesis of gastric cancer , 1999, Alimentary pharmacology & therapeutics.

[42]  Z. W. Zhang,et al.  The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach , 1998, Gut.

[43]  C. O'Morain,et al.  Treatment of Helicobacter pylori , 2005, Helicobacter.

[44]  L. Cellini,et al.  Recovery of Helicobacter pylori ATCC43504 from a viable but not culturable state: regrowth or resuscitation? , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[45]  G. Woodnutt,et al.  Bactericidal and morphological effects of amoxicillin on Helicobacter pylori , 1995, Antimicrobial agents and chemotherapy.

[46]  J. Rood,et al.  Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. , 1994, The American journal of gastroenterology.

[47]  A. Fox,et al.  An ultrastructural study of the gastric campylobacter-like organism 'Campylobacter pyloridis'. , 1985, Journal of general microbiology.

[48]  Thomas K. Hunt,et al.  ON THE TREATMENT OF , 1846 .

[49]  R. Corti,et al.  [Role of Helicobacter pylori coccoid forms in infection and recrudescence]. , 2016, Gastroenterologia y hepatologia.

[50]  J. Oliver,et al.  Bridging the gap between viable but non-culturable and antibiotic persistent bacteria. , 2015, Trends in microbiology.

[51]  J. Pincemail,et al.  [Oxidative stress]. , 2007, Revue medicale de Liege.

[52]  R. Colwell,et al.  Nonculturable Microorganisms in the Environment , 2000, Springer US.

[53]  C. Williams Helicobacter pylori: bacteriology and laboratory diagnosis. , 1997, The Journal of infection.